Personal information

Other IDs

Loop profile: 376666
Scopus Author ID: 55626094100
Scopus Author ID: 6504623622

Activities

Collapse all

Employment (4)

Vanderbilt University Medical Center: Nashville, TN, US

2021-10-01 to present | Research Assistant Professor
Employment
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan

Vanderbilt University Medical Center: Nashville, TN, US

2018-10-01 to 2021-09-30 | Research Instructor (Allergy, Pulmonary and Critical Care Medicine)
Employment
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan

Vanderbilt University Medical Center: Nashville, TN, US

2016-01-11 to 2018-09-30 | Post Doctoral Fellow (Allergy, Pulmonary and Critical Care Medicine)
Employment
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan

University of Florida/College of Pharmacy: Gainesville, FL, US

2015-08-20 to 2015-12-31 | Post Doctoral Associate (Pharmacodynamics)
Employment
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan

Education and qualifications (3)

University of Florida: Gainesville, FL, US

2009-06-20 to 2015-08-15 | PhD (Pharmacodynamics)
Education
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan

Anna University Chennai: Chennai, Tamil Nadu, IN

2001-02-12 to 2003-08-15 | MS (By Research) (Center For Biotechnology)
Education
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan

JSS College of Pharmacy: Ootacamund, Tamil Nadu, IN

1995-07-24 to 1999-05-20 | B.Pharmacy
Education
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan

Funding (1)

Targeting Metabolism to Rescue Vascular Function in PAH

2019-02 to 2022-01 | Award
Vanderbilt University Medical Center (TN, TN, US)
GRANT_NUMBER: VFRS AWARD
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan

Works (24)

Thromboxane-Prostanoid Receptor Signaling Drives Persistent Fibroblast Activation in Pulmonary Fibrosis.

American journal of respiratory and critical care medicine
2022-06-21 | Journal article
DOI: 10.1164/rccm.202106-1503oc
PMID: 35728047
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan

Differential serum lipid distribution in IPAH and CHD-PAH patients

Respiratory Medicine
2022-01 | Journal article
DOI: 10.1016/j.rmed.2021.106711
Contributors: Jingyuan Chen; Anandharajan Rathinasabapathy; Jun Luo; Xiaojie Yang; Peng Luo; Yusi Chen; Zilu Li; Jiang Li
Source: check_circle
Crossref

Prevalence of Schistosoma japonicum–associated Pulmonary Hypertension in China: An Echocardiography-based Assessment

Annals of the American Thoracic Society
2021-12 | Journal article
DOI: 10.1513/AnnalsATS.202012-1573RL
Contributors: Xiaofang Zeng; Xiao Huang; Anandharajan Rathinasabapathy; Zhe Xu; Kai Li; Na Liu; Huiling Chen; Yuandong Jiang; Lihuang Zha; Zaixin Yu
Source: check_circle
Crossref

Association of cardiac injury with hypertension in hospitalized patients with COVID-19 in China

Scientific Reports
2021-11-17 | Journal article
DOI: 10.1038/s41598-021-01796-0
Contributors: Xiaofang Zeng; Anandharajan Rathinasabapathy; Dongliang Liu; Lihuang Zha; Xiangwei Liu; Yiyang Tang; Famei Li; Wenchao Lin; Zaixin Yu; Huiling Chen
Source: check_circle
Crossref

Overexpression of Msx1 in Mouse Lung Leads to Loss of Pulmonary Vessels Following Vascular Hypoxic Injury

Cells
2021-09-03 | Journal article
DOI: 10.3390/cells10092306
Contributors: James West; Anandharajan Rathinasabapathy; Xinping Chen; Sheila Shay; Shanti Gladson; Megha Talati
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse Models

International Journal of Molecular Sciences
2021-05 | Journal article | Author
DOI: 10.3390/ijms22095014
Contributors: James D. West; Eric D. Austin; Elise M. Rizzi; Ling Yan; Harikrishna Tanjore; Amber L. Crabtree; Christy S. Moore; Gladson Muthian; Erica J. Carrier; David A. Jacobson et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Expression of a Human Caveolin-1 Mutation in Mice Drives Inflammatory and Metabolic Defect-Associated Pulmonary Arterial Hypertension

Frontiers in Medicine
2020 | Journal article
DOI: 10.3389/fmed.2020.00540
EID:

2-s2.0-85091514779

Part of ISSN: 2296858X
Contributors: Rathinasabapathy, A.; Copeland, C.; Crabtree, A.; Carrier, E.J.; Moore, C.; Shay, S.; Gladson, S.; Austin, E.D.; Kenworthy, A.K.; Loyd, J.E. et al.
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan via Scopus - Elsevier

Rapid disease progress in a PVOD patient carrying a novel EIF<inf>2</inf>AK<inf>4</inf>mutation: A case report

BMC Pulmonary Medicine
2020 | Journal article
DOI: 10.1186/s12890-020-01186-8
EID:

2-s2.0-85087667500

Part of ISSN: 14712466
Contributors: Zeng, X.; Chen, F.; Rathinasabapathy, A.; Li, T.; Adnan Ali Mohammed Mohammed, A.; Yu, Z.
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan via Scopus - Elsevier

Complementary Embryonic and Adult Cell Populations Enhance Myocardial Repair in Rat Myocardial Injury Model

Stem Cells International
2019-11-03 | Journal article
DOI: 10.1155/2019/3945850
Contributors: Sergio Li Calzi; Todd Cook; Domenico G. Della Rocca; Juan Zhang; Vinayak Shenoy; Yuanqing Yan; Andrew Espejo; Anandharajan Rathinasabapathy; Max H. Jacobsen; Tatiana Salazar et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Ubiquitin chains: a new way of screening for regulatory differences in pulmonary hypertension.

Pulmonary circulation
2018-07-01 | Journal article
DOI: 10.1177/2045894018796782
PMID: 30124137
PMC: PMC6109854
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan
grade
Preferred source (of 2)‎

A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension.

The European respiratory journal
2018-06-21 | Journal article
DOI: 10.1183/13993003.02638-2017
PMID: 29903860
PMC: PMC6613216
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan
grade
Preferred source (of 2)‎

Involvement of Neuroinflammation in the Pathogenesis of Monocrotaline-Induced Pulmonary Hypertension.

Hypertension (Dallas, Tex. : 1979)
2018-04-30 | Journal article
DOI: 10.1161/HYPERTENSIONAHA.118.10934
PMID: 29712738
PMC: PMC5945302
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan
grade
Preferred source (of 2)‎

rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling.

Frontiers in physiology
2018-04-09 | Journal article
DOI: 10.3389/fphys.2018.00271
PMID: 29731719
PMC: PMC5922219
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan
grade
Preferred source (of 2)‎

The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury.

Frontiers in physiology
2018-03-27 | Journal article
DOI: 10.3389/fphys.2018.00180
PMID: 29636695
PMC: PMC5881224
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan
grade
Preferred source (of 2)‎

Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension.

American journal of physiology. Lung cellular and molecular physiology
2017-09-21 | Journal article
DOI: 10.1152/ajplung.00296.2017
PMID: 28935639
PMC: PMC5866427
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan
grade
Preferred source (of 2)‎

Therapeutic potential of adipose stem cell-derived conditioned medium against pulmonary hypertension and lung fibrosis.

British journal of pharmacology
2016-08-26 | Journal article
DOI: 10.1111/bph.13562
PMID: 27448286
PMC: PMC5275771
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan
grade
Preferred source (of 2)‎

Stem cell therapy restores viscoelastic properties of myocardium in rat model of hypertension.

Journal of the mechanical behavior of biomedical materials
2015-12-19 | Journal article
DOI: 10.1016/j.jmbbm.2015.11.041
PMID: 26748260
PMC: PMC4860127
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan

Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.

British journal of pharmacology
2015-02-27 | Journal article
DOI: 10.1111/bph.13044
PMID: 25522140
PMC: PMC4403089
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan
grade
Preferred source (of 2)‎

Oral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension.

Hypertension (Dallas, Tex. : 1979)
2014-09-15 | Journal article
DOI: 10.1161/HYPERTENSIONAHA.114.03871
PMID: 25225206
PMC: PMC4239698
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan
grade
Preferred source (of 2)‎

Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models.

American journal of respiratory and critical care medicine
2013-01-31 | Journal article
DOI: 10.1164/rccm.201205-0880OC
PMID: 23370913
PMC: PMC3733435
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan
grade
Preferred source (of 2)‎

18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.

Metabolism: clinical and experimental
2009-07-15 | Journal article
DOI: 10.1016/j.metabol.2009.04.036
PMID: 19608207
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan
grade
Preferred source (of 2)‎

In vitro glucose uptake activity of Aegles marmelos and Syzygium cumini by activation of Glut-4, PI3 kinase and PPARgamma in L6 myotubes.

Phytomedicine : international journal of phytotherapy and phytopharmacology
2005-11-02 | Journal article
DOI: 10.1016/j.phymed.2005.03.008
PMID: 16716914
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan
grade
Preferred source (of 2)‎

Upregulation of Glut-4 and PPAR gamma by an isoflavone from Pterocarpus marsupium on L6 myotubes: a possible mechanism of action.

Journal of ethnopharmacology
2005-01-13 | Journal article
DOI: 10.1016/j.jep.2004.11.023
PMID: 15707762
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan
grade
Preferred source (of 2)‎

Non-Compliance - A Study in selected areas

The Indian Journal of Hospital Pharmacy
2001-03 | Journal article
Source: Self-asserted source
R. Anandharajan, Anandharajan Rathinasabapathy, A Rathinasabapathy, Rathinasabapathy Anandharajan

Peer review (2 reviews for 2 publications/grants)

Review activity for Molecular medicine. (1)
Review activity for PloS one. (1)
How many people are using ORCID?